Current treatment status-Currently treated,Monotherapy with MTX Posts on Medivizor
Navigation Menu

Current treatment status-Currently treated,Monotherapy with MTX Posts on Medivizor

Methotrexate combined with a TNF-inhibitor slows joint damage more than methotrexate alone

Posted by on Aug 4, 2014 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether a combination of methotrexate and tumor-necrosis factor inhibitors was more effective in treatment of rheumatoid arthritis than methotrexate alone. Some background Rheumatoid arthritis is a chronic (long-term) disease, therefore the focus of treatment is to prevent joint damage and slow the progression of...

Read More